Page 12 - Maat Pharma News Today : Breaking News, Live Updates & Top Stories | Vimarsana

MaaT Pharma: Monthly Information Regarding the Total Number of Voting Rights and Shares Comprising the Share Capital

MaaT Pharma: Monthly Information Regarding the Total Number of Voting Rights and Shares Comprising the Share Capital
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Guilhaume debroasPauline richaudRegulations of the financial markets authorityCorporate communicationsTrophic communicationsGeneral regulationsFinancial markets authorityDes marchMicrobiome ecosystemFrench commercial codeFrench autoritEuronext parisMaat pharmaMicrobiome ecosystem therapiesInvestor relationsMedia relations

MaaT Pharma: Monthly Information Regarding the Total Number of Voting Rights and Shares Comprising t

Article 223-16 of the General Regulations of the Financial Markets Authority(AMF - Autorité des Marchés Financiers)LYON, France (BUSINESS WIRE) $MAAT Regulatory News:MaaT Pharma (EURONEXT: MAAT – the “Company”), a clinical-stage biotechnology company and a leader in the development of Microbiome Ecosystem Therapi.

Guilhaume debroasPauline richaudRegulations of the financial markets authorityGeneral regulationsFinancial markets authorityDes marchRegulatory newsMicrobiome ecosystemFrench commercial codeFrench autoritMaat pharmaMicrobiome ecosystem therapiesEuronext parisInvestor relations

MaaT Pharma Announces Poster Presentations at the 38th Annual Meeting of the Society for Immunotherapy of Cancer (SITC)

MaaT Pharma Announces Poster Presentations at the 38th Annual Meeting of the Society for Immunotherapy of Cancer (SITC)
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

San diegoUnited statesBaden wübergSenior pr corporate communicationsTrophic communications corporateSociety for immunotherapy of cancerImmune checkpoint inhibitorsMicrobiome ecosystemAnnual meetingArtificial intelligenceRobust machine learningScreening microbiome ecosystem therapiesDrug candidatesMaat pharmaMicrobiome ecosystem therapiesEuronext paris

Graft Versus Host Disease Market to Witness Upsurge in Growth During the Forecast Period (2023-2032), Assesses DelveInsight | Key Companies - Glia, Incyte, Novartis, GlaxoSmithKline, Pfizer, BMS, Roche, AstraZeneca, Sanofi

DelveInsight's Graft Versus Host Disease Market.

United kingdomUnited statesBristol mayers squibbShruti thakurBristol myers squibbOncoimmune merckPrnewswire delveinsightOncoimmune incAssesses delveinsight key companiesNovartis pharmaceuticalsSeres therapeutics incMarket researchSyndax pharmaceuticalsKey graft versus host disease companiesBellicum pharmaceuticalsKadmon pharmaceuticals

MaaT Pharma Announces Poster Presentations at the 38th Annual Meeting of the Society for Immunotherapy of Cancer (SITC)

MaaT Pharma Announces Poster Presentations at the 38th Annual Meeting of the Society for Immunotherapy of Cancer (SITC)
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesSan diegoSociety for immunotherapy of cancerSenior pr corporate communicationsTrophic communicationsCorporate communicationsImmune checkpoint inhibitorsMicrobiome ecosystemAnnual meetingArtificial intelligenceRobust machine learningScreening microbiome ecosystem therapiesDrug candidatesMaat pharmaMicrobiome ecosystem therapiesEuronext paris